NewsBenzingaUsana Health Sciences, FY2026 Düzeltilmiş Hisse Başına Kâr (EPS) Tahminini 0,76 Dolardan 0,55 Dolara Düşürdü; FY2026 Satış Tahminini 910,000 Milyon Dolardan 900,000 Milyon Dolara İndirdi; Beklenti 908,995 Milyon Dolar İdi Usana Health Sciences, FY2026 Düzeltilmiş Hisse Başına Kâr (EPS) Tahminini 0,76 Dolardan 0,55 Dolara Düşürdü; FY2026 Satış Tahminini 910,000 Milyon Dolardan 900,000 Milyon Dolara İndirdi; Beklenti 908,995 Milyon Dolar İdi Benzinga 2026.11.03 21:22 (GMT+0) Open on Benzinga Other news Ashland Sees FY2027 Sales $1.905B-$1.975B vs $1.929B Est CORRECTION: Booking Holdings Q3 Adj. EPS $4.66 Beats $4.50 Estimate, Sales $9.793B Beat $9.548B Estimate Global Water Resources Q3 Adj. EPS $0.03 Misses $0.05 Estimate, Sales $16.301M Beat $16.000M Estimate Toast Shares Slide After Q3 Earnings, CFO Transition Plans AMD CEO Says Expect Our Embedded Business To Deliver A Strong Double-Digit Annual Revenue Growth; Now Expect Revenue To Grow More Than 80% In 2027 National Bank Holdings Increases Quarterly Dividend From $0.32 To $0.33 Per Share
CORRECTION: Booking Holdings Q3 Adj. EPS $4.66 Beats $4.50 Estimate, Sales $9.793B Beat $9.548B Estimate
Global Water Resources Q3 Adj. EPS $0.03 Misses $0.05 Estimate, Sales $16.301M Beat $16.000M Estimate
AMD CEO Says Expect Our Embedded Business To Deliver A Strong Double-Digit Annual Revenue Growth; Now Expect Revenue To Grow More Than 80% In 2027
